Cyramza Masterclass

Activity: Consultancy types › Work on advisory panel to industry or government or non-government organisation

Description

Presentation of research and relevant to the development of the angiogenesis inhibitor Ramucirumab. I presented our work on angiogenesis biomarkers.
Period22 Jun 2015 → 23 Jun 2015
Work forEli Lilly & Company Ltd, United Kingdom
Degree of RecognitionNational